| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |